Alternatives to Mybiotics Pharma

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

AI-driven digital twin of embryo development for cell-based therapies.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

AI-powered platform for designing novel molecular structures for new medicines.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A vertically-integrated procurement platform for the life sciences industry.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

A global leader in clinical pharmacology and bioanalytical sciences.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Biotechnology company specializing in antibody discovery and protein engineering for therapeutic applications.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

AI-powered knowledge discovery for life sciences.

Omnix Medical is developing a novel platform for advanced wound care management.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

Engineering scalable gene therapies for broader patient populations.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

AI-powered antibody discovery platform.

Therapeutics company developing novel treatments for complex diseases.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Pioneering vision restoration therapies for severe retinal degenerations.

Revolutionary technology enabling cultured meat at price parity with animal meat.

AI-powered email management and scientific research platforms.

Compressing biology to develop the next generation of therapies.

AI-driven predictive modeling company focused on biology and life sciences.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

Scalable, one-time curative in-vivo gene editing therapies.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.

Building General Biological Intelligence

Synthetic biology startup optimizing gene expression for food and biotech applications.

Develops and distributes bioreactor technology for stem cell cultivation.

Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.

Platform designed to cut cell and gene therapy production costs.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

AI-enabled technology for cell biology research and biopharma development.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.